A novel approach using transcomplementing adenoviral vectors for gene therapy of adrenocortical cancer

Hormone and Metabolic Research

Volumn 34, Issue 6, 2002, Pages 279-287

  Wolkersdorfer G W ^d   Bornstein, S R ^a,e   Higginbotham, J N ^c   Hiroi, N ^a   Vaquero, J J ^b   Green, M V ^b   Blaese, R M ^c   Aguilera, G ^a   Chrousos, G P ^a   Ramsey, W J ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Adenovirus; Adrenal Gland; Bicistronic; Cancer; Gene Therapy; Transcomplementing

Indexed keywords

ADENOVIRUS VECTOR; PRODRUG; THYMIDINE KINASE; ANTIVIRUS AGENT; DNA FRAGMENT; GANCICLOVIR;

ADRENAL CORTEX CARCINOMA; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL DEATH; CELL NUCLEUS INCLUSION BODY; CELL ULTRASTRUCTURE; CISTRON; CONTROLLED STUDY; CYTOTOXICITY; GENE AMPLIFICATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SUICIDE GENE; SURVIVAL TIME; VIRUS REPLICATION; ADENOVIRUS; ADRENAL CORTEX TUMOR; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ELECTRON MICROSCOPY; ENZYMOLOGY; FEMALE; FLOW CYTOMETRY; GENE VECTOR; GENETICS; METHODOLOGY; MOUSE; NUDE MOUSE; RESTRICTION MAPPING;

ADENOVIRIDAE; ADRENAL CORTEX NEOPLASMS; ANIMAL; ANTIVIRAL AGENTS; APOPTOSIS; DNA FRAGMENTATION; FEMALE; FLOW CYTOMETRY; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMAN; MICE; MICE, NUDE; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; RESTRICTION MAPPING; SIMPLEXVIRUS; THYMIDINE KINASE; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR CELLS, CULTURED; ANIMALS; HUMANS;

ADENOVIRIDAE; ANIMALIA; SIMPLEXVIRUS;

EID: 0035988634     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-33255     Document Type: Article

References (56)

1. Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection
2. Childhood adrenocortical tumors: Case series and reevaluation of prognosis - A 24-year experience
3. Clinical and prognostic aspects of adrenocortical neoplasms in childhood
4. Adrenocortical tumors: Recent advances in basic concepts and clinical management
5. MHC class II expression - A new tool to assess dignity in adrenocortical tumours
6. Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome
7. o,p′-DDD (mitotane) therapy of adrenal cortical carcinoma: Observations on drug dosage, toxicity, and steroid replacement
8. Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma
9. Treatment of metastatic adrenal cortical carcinoma with etoposide (VP-16) and cisplatin after failure with o,p′DDD. Clinical case reports
10. Histological study of adrenal cortical carcinoma in gonadectomized mice of the ce strain
11. Regression of an adrenal cortical carcinoma by estradiol treatment
12. New human cancer cell culture lines. I. SW-13, small-cell carcinoma of the adrenal cortex
13. The antiproliferative effect of suramin on the cancer cell line SW-13 is mediated by the inhibition of transforming growth factor beta 1 (TGF-beta 1)
14. Suramin in adrenal cancer: Modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect
15. An in vitro and in vivo study of antitumor effects of gossypol on human SW-13 adrenocortical carcinoma
16. Gene therapy - Promises, problems and prospects
17. Cytokine gene therapy: Hopes and pitfalls
18. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography
19. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases
20. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
21. Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth
22. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
23. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors
24. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy
25. Mechanism of "bystander effect" killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment
26. The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication
27. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins
28. Adeno-retroviral chimeric viruses as in vivo transducing agents
29. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
30. Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer
31. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
32. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors
33. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration
34. Adenovirus early region 4 and viral DNA synthesis
35. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
36. Gut epithelial cells as targets for gene therapy of hemophilia
37. Defective transforming capacity of adenovirus type 5 host-range mutants
38. Efficient directional cloning of recombinant adenovirus vectors using DNA-protein complex
39. Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes
40. Adenovirus type 5 E4 open reading frame 4 protein induces apoptosis in transformed cells
41. The early region 4orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis
42. Complementary adenoviral vectors for oncolysis
43. Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy
44. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase
45. Cell-cell communication in carcinogenesis
46. Role of connexin (gap junction) genes in cell growth control and carcinogenesis
47. Alpha1 connexin 43 gap junctions are decreased in human adrenocortical tumors
48. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions
49. Evaluation of apoptotic parameters in normal and neoplastic human adrenal
50. Lymphocytes stimulate dehydroepiandrosterone production through direct cellular contact with adrenal zona reticularis cells: A novel mechanism of immune-endocrine interaction
51. The rhesus macaque as an animal model for hemophilia B gene therapy
52. Early region 4 modulates adenovirus DNA replication by two genetically separable mechanisms
53. Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter
54. Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription
55. Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1
56. Adenovirus recombination: Physical mapping of crossover events